Q4 FY26 — 5 May 2026
Star Health Insu Q4 FY26
Star Health reported a strong FY26 with underwriting profit turning positive and normalized PAT growing 45% YoY, driven by strategic recalibration and improved operating levers. Despite a Q4 loss due to marked-to-market adjustments, the company emphasized its focus on quality of growth, customer experience, and digital transformation. Management remains confident in sustained high-teen growth and mid-teen ROEs, while addressing concerns around retail loss ratios and market share.
Read the full call






